Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032

标题

作者

关键词

SCLC, Third-line, Nivolumab, PD-1 inhibitor, Immunotherapy

出版物

Volume 14, Issue 2, Pages 237-244

出版商

Elsevier BV

发表日期

2018-10-11

DOI

10.1016/j.jtho.2018.10.003

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now